Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

Corporate Breaking News

Home : Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

Jan 11 2021	Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference
Commercial launch activities for IdefirixÂ® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was reinitiated in December 2020 Year-end cash position of SEK 1.4 billion LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- Hansa Biopharma, the leader in...


Source:https://www.prnewswire.com:443/news-releases/hansa-biopharma-provides-business-update-incl-certain-key-financials-ahead-of-the-jp-morgan-global-healthcare-conference-301204955.html

Related News
» Mr. Mahesh Parlikad to Speak at TKG’s Antitrust Issues Amid the Pandemic: What Companies and Financial Institutions Must Know and Do Webcast » Zoomd lance la version SaaS libre-service de sa plateforme intelligente de gestion de campagne